Tunisia
Tunisia
Explore linked clinical trials.32 results · Page 1 of 2
Cities
Swipe the table sideways for more columns.
| Cities | City | Country | Linked trials |
|---|---|---|---|
| Aryanah | Aryanah | Tunisia | 3 |
| Ben Arous | Ben Arous | Tunisia | 2 |
| Ben Arous | Ben Arous | Tunisia | 1 |
| El Kef | El Kef | Tunisia | 1 |
| Kairouan | Kairouan | Tunisia | 1 |
| LA Mannouba | LA Mannouba | Tunisia | 1 |
| La Rabta | La Rabta | Tunisia | 1 |
| Mahdia | Mahdia | Tunisia | 1 |
| Mahdia | Mahdia | Tunisia | 1 |
| Mannouba | Mannouba | Tunisia | 2 |
| Manouba | Manouba | Tunisia | 1 |
| Manouba | Manouba | Tunisia | 1 |
| Manouba | Manouba | Tunisia | 1 |
| Monastir | Monastir | Tunisia | 11 |
| Monastir | Monastir | Tunisia | 7 |
| Monastir | Monastir | Tunisia | 1 |
| Monastir | Monastir | Tunisia | 1 |
| Montfleury | Montfleury | Tunisia | 1 |
| Nabeul | Nabeul | Tunisia | 5 |
| Nabeul | Nabeul | Tunisia | 1 |
| Sfax | Sfax | Tunisia | 15 |
| Sfax | Sfax | Tunisia | 1 |
| Sousse | Sousse | Tunisia | 20 |
| Sousse | Sousse | Tunisia | 1 |
| Tunis | Tunis | Tunisia | 2 |
89 results · Page 1 of 4
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee Arthroplasty | Embolism and Thrombosis, Thromboembolism, cardiovascular disorder, vascular disorder, venous thromboembolism | Recruiting | Not applicable | 2026-10-09 | NCT07869615 | |
| A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, chronic renal failure syndrome, heart disorder, kidney disorder, kidney failure, nervous system disorder, stroke disorder, urinary system disorder, vascular disorder | Recruiting | Phase 3 | 2026-10-08 | NCT07241390 | |
| TRiP-cast Score Validation and Evaluation of Adherence to Preventive Anticoagulant Treatment in Patients With Lower Limb Trauma Requiring Immobilization | Deep Vein Thrombosis, Embolism, Embolism and Thrombosis, Thromboembolism, Venous Thrombosis, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, thrombotic disease, vascular disorder, venous thromboembolism | Recruiting | Not stated | 2026-10-07 | NCT07863115 | |
| Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria | Chronic Disease, Chronic Spontaneous Urticaria, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Enrolling by invitation | Phase 3 | 2026-10-07 | NCT07256392 | |
| Virtual Reality-Augmented Constraint-Induced Movement Therapy Versus Conventional Constraint-Induced Therapy for Upper Limb Rehabilitation in Children With Unilateral Cerebral Palsy. | Cerebral Palsy Spastic Hemiplegic, Quality of Movement | Not yet recruiting | Not applicable | 2026-10-02 | NCT07853937 | |
| Evaluation of the Effectiveness of the Cardiostory Device in Distinguishing Heart Failure From Other Causes in Patients Presenting With Dyspnea. | Dyspnea, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, cardiovascular disorder, heart disorder, heart failure, respiratory system disorder | Recruiting | Not stated | 2026-10-02 | NCT07685106 | |
| A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-09-28 | NCT03466411 | |
| Controlled Versus Standard Oxygen Therapy in ICU Patients With Acute Exacerbation of COPD | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Not applicable | 2026-09-25 | NCT07842510 | |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Active, not recruiting | Phase 3 | 2026-09-24 | NCT03958877 | |
| A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Active, not recruiting | Phase 3 | 2026-09-23 | NCT04812925 | |
| Effects of Whole-Body Electromyostimulation in Overweight/Obese Postmenopausal Women | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Not applicable | 2026-09-22 | NCT07826754 | |
| A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-09-21 | NCT05894239 | |
| A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) | Relapsing Multiple Sclerosis | Active, not recruiting | Phase 3 | 2026-09-21 | NCT04586010 | |
| A Long-Term Observational Study of Patients With Fucosidosis | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, fucosidosis, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, nervous system disorder | Recruiting | Not stated | 2026-09-17 | NCT07615400 | |
| Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects | Body Weight, Insulin Resistance, Nutritional and Metabolic Diseases, Obesity, Abdominal, Overweight, Pathological Conditions, Signs and Symptoms, Schizophrenia Spectrum and Other Psychotic Disorders, Schizophrenia, Treatment-Resistant, Signs and Symptoms, glucose metabolism disease, hyperinsulinism, metabolic disease, nutritional disorder, obesity disorder, overnutrition, psychiatric disorder, schizophrenia | Recruiting | Not applicable | 2026-09-14 | NCT07817069 | |
| Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity | Early Stage Ovarian Tumors; Sentinel Lymph Node Biopsy (SLNB) | Recruiting | Not stated | 2026-09-10 | NCT07508306 | |
| Optimization of Basal Insulin During Ramadan Fasting in Type 2 Diabetic Patients: Comparison Between DAR Recommendations and the Carbohydrate Fasting Test & Metabolic and Inflammatory Consequences | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Active, not recruiting | Early phase 1 | 2026-09-10 | NCT06826547 | |
| A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study) | Non Squamous Non Small Cell Lung Cancer | Active, not recruiting | Phase 3 | 2026-09-10 | NCT06687369 | |
| Office Hysteroscopy in Postmenopausal Women: A Randomized Trial of Cervical Preparation Strategies | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hemorrhage, Metrorrhagia, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Uterine Hemorrhage, female reproductive system disorder, uterine disorder | Recruiting | Not applicable | 2026-09-09 | NCT07697781 | |
| A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, generalized pustular psoriasis, psoriasis, skin disorder | Active, not recruiting | Phase 4 | 2026-09-02 | NCT06013969 | |
| Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, generalized pustular psoriasis, psoriasis, skin disorder | Active, not recruiting | Phase 2 | 2026-09-01 | NCT03886246 | |
| High- vs Standard-Dose Intravenous Magnesium for Acute Headache | Acute Pain, Disease Attributes, Emergencies, Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tension-Type Headache, agnosia, brain disorder, central nervous system disorder, cluster headache syndrome, headache disorder, hypnic headache, migraine disorder, nervous system disorder, perceptual disorders, trigeminal autonomic cephalalgia | Recruiting | Not applicable | 2026-08-21 | NCT07779486 | |
| Effectiveness and Utility of Telemonitoring in Improving the Glycaemic Control of Diabetes Mellitus Tunisian Patients | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Recruiting | Not applicable | 2026-08-20 | NCT07774078 | |
| Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, heart disorder, patent ductus arteriosus | Recruiting | Not stated | 2026-08-12 | NCT05264753 | |
| VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-08-07 | NCT05724433 |